BMO Capital upgraded Mylan (NASDAQ: MYL) from Underperform to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change Upgrades

Teva Pharma (TEVA) Offers $82/Share for Mylan (MYL)April 21, 2015 8:46 AM Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and StockApril 21, 2015 8:45 AM Teva (TEVA) May Approach Mylan (MYL) as Soon as Tuesday - BloombergApril 21, 2015 6:37 AM